Morgan Stanley’s DarioHealth DRIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $19.8K | Buy |
3,000
+2,000
| +200% | +$14.9K | ﹤0.01% | 6827 |
|
|
2026
Q1 | $8.02K | Buy |
+1,000
| New | +$10.4K | ﹤0.01% | 7014 |
|
|
2025
Q4 | – | Sell |
-61
| Closed | -$1.06K | – | 8267 |
|
|
2025
Q3 | $1.06K | Buy |
+61
| New | +$672 | ﹤0.01% | 7387 |
|
|
2025
Q2 | – | Sell |
-259
| Closed | -$3.17K | – | 8143 |
|
|
2025
Q1 | $3.17K | Buy |
+259
| New | +$3.65K | ﹤0.01% | 7091 |
|
|
2024
Q3 | – | Sell |
-5,041
| Closed | -$120K | – | 7948 |
|
|
2024
Q2 | $120K | Sell |
5,041
-165
| -3% | -$4.68K | ﹤0.01% | 5900 |
|
|
2024
Q1 | $159K | Buy |
5,206
+843
| +19% | +$32K | ﹤0.01% | 5802 |
|
|
2023
Q4 | $150K | Buy |
4,363
+1,534
| +54% | +$54.6K | ﹤0.01% | 5792 |
|
|
2023
Q3 | $186K | Buy |
2,829
+1,871
| +195% | +$126K | ﹤0.01% | 5616 |
|
|
2023
Q2 | $76.9K | Sell |
958
-799
| -45% | -$60.7K | ﹤0.01% | 6055 |
|
|
2023
Q1 | $145K | Sell |
1,757
-256
| -13% | -$25.1K | ﹤0.01% | 5852 |
|
|
2022
Q4 | $172K | Sell |
2,013
-199
| -9% | -$17.9K | ﹤0.01% | 5729 |
|
|
2022
Q3 | $204K | Buy |
2,212
+925
| +72% | +$99.3K | ﹤0.01% | 5715 |
|
|
2022
Q2 | $159K | Buy |
1,287
+56
| +5% | +$6.57K | ﹤0.01% | 6001 |
|
|
2022
Q1 | $144K | Sell |
1,231
-2,053
| -63% | -$340K | ﹤0.01% | 6098 |
|
|
2021
Q4 | $853K | Buy |
3,284
+1,896
| +137% | +$577K | ﹤0.01% | 5185 |
|
|
2021
Q3 | $379K | Buy |
1,388
+806
| +138% | +$233K | ﹤0.01% | 5660 |
|
|
2021
Q2 | $249K | Buy |
582
+405
| +229% | +$154K | ﹤0.01% | 5899 |
|
|
2021
Q1 | $68K | Buy |
177
+121
| +216% | +$54.5K | ﹤0.01% | 6204 |
|
|
2020
Q4 | $16K | Buy |
56
+26
| +87% | +$6.7K | ﹤0.01% | 6495 |
|
|
2020
Q3 | $10K | Buy |
30
+15
| +100% | +$4.06K | ﹤0.01% | 6271 |
|
|
2020
Q2 | $2K | Buy |
+15
| New | +$1.99K | ﹤0.01% | 6442 |
|
|
2018
Q1 | – | Sell |
-14
| Closed | -$9K | – | 6631 |
|
|
2017
Q4 | $9K | Hold |
14
| – | – | ﹤0.01% | 6233 |
|
|
2017
Q3 | $10K | Buy |
+14
| New | +$12.4K | ﹤0.01% | 6169 |
|
|
2017
Q2 | – | Sell |
-63
| Closed | -$75K | – | 6599 |
|
|
2017
Q1 | $75K | Buy |
+63
| New | +$93.5K | ﹤0.01% | 5706 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 6538 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 6602 |
|
Other funds holding DRIO
NCM
Morgan Stanley's DRIO Position: Q2 2026 in Review
Morgan Stanley increased its DarioHealth (DRIO) stake by 200% in Q2 2026, buying an estimated $14.9K and bringing the position to 3,000 shares worth $19.8K. The position accounts for ﹤0.01% of the portfolio, ranked #6827.
Morgan Stanley first reported a position in DRIO in Q1 2017 and has held it in 24 quarters since. The position peaked at $853K in Q4 2021. 21 funds tracked by Wall St. Rank hold DRIO as of Q2 2026.
- Morgan Stanley held 3,000 shares of DarioHealth worth $19.8K as of Q2 2026.
- Morgan Stanley bought 2,000 DarioHealth shares in Q2 2026, an estimated $14.9K.
- DarioHealth made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #6827 holding.
- Morgan Stanley first reported a position in DarioHealth in Q1 2017 and has held it in 24 quarters since.
- Morgan Stanley's DarioHealth position peaked at $853K in Q4 2021.
- 21 funds tracked by Wall St. Rank held DarioHealth as of Q2 2026.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.